News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Clinical Trial Alert: PTC Therapeutics Seeks Participants for a Phase 3 DMD Study

Blog Post

Muscular Dystrophy Association Bridges Clinical and Academic Neuromuscular Research for the First Time at Annual Meeting

Blog Post

MDA Partners with the Broad Institute on Rare Genomes Project for Limb-Girdle Muscular Dystrophy

Blog Post

Audentes Therapeutics Announces Plans to Develop Gene-Targeted Therapies for Duchenne Muscular Dystrophy and Myotonic Dystrophy Type 1

Blog Post

Muscular Dystrophy Association Awards Eight Grants Totaling More Than $2 Million for ALS Research

Blog Post

Sarepta Therapeutics Announces Positive Interim Results from Study of Casimersen to Treat DMD Amenable to Exon 45 Skipping

Blog Post

FDA Grants Orphan Drug Designation to Acceleron Pharma’s ACE-083 Muscle Growth Drug for Charcot-Marie-Tooth Disease

Blog Post

Clinical Trial Alert: Researchers at Neurogene Seek Participants for a CMT4J Natural History Study

Blog Post

Sarepta Therapeutics Announces Positive Interim Results in Gene Therapy Trial for LGMD2E and Acquisition of Myonexus Therapeutics

Blog Post

Clinical Trial Alert: ReveraGen BioPharma Seeks Participants for a Phase 2b DMD Study